When to stop Stop the protocol and contact your provider if you experience persistent redness or swelling at injection sites beyond 72 hours, fever, or any systemic symptom that does not correlate with the expected mild post-injection reaction
Although Phase 2 data have demonstrated impressive cardiometabolic benefits, retatrutide remains unlicensed by the MHRA and EMA, meaning its full side-effect profile including any musculoskeletal effects is not yet formally established
Here, we focused primarily on the acute mitochondrial impact of 5FU, and although we arrived at the combination of 5FU and mitochondrial inhibitors (more specifically, 5FU and metformin) somewhat serendipitously, we have now generated evidence to support the use of 5FU and metformin combinations not only in patients with resistant or relapsed disease as previously suggested by others, but also in treatment-naive, first-line chemotherapy settings
Test Spot Requirement Not required
Helps eliminate free radicals and boosts immunity